S.A. Popov¹, T.P. Sabgayda^2
1Institute Phthisiopulmonology, "First Moscow State Medical University named after IM Sechenov", Moscow
²Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation, Moscow

Summary. The spread of drug-resistant TB in different regions with different rates requires to organize the monitoring of biological characteristics of Mycobacterium tuberculosis based on the data of modern molecular biological methods of investigation. It is proposed to develop the tiered laboratory information-analytical system as the basis of microbiological monitoring in Russia.

The purpose of this study was to formulate the main problems in organization of diagnostic for drug susceptibility of Mycobacterium tuberculosis to prevent the use of the results of molecular genetics and microbiological research techniques to support strategic plans for TB control as well as to develop proposals for solutions of these problems on the basis of the laboratory information-analytical system.

It was shown that for effective microbiological monitoring of tuberculosis is necessary to solve the next problems: the ensuring the reliability of data on drug-resistant TB; accounting for all epidemiologically important groups of patients in the form of statistical reporting; the collection and summing on the national level of data on drug-resistant TB for the entire spectrum of TB drugs; standardization of molecular genetics techniques to determine transmission ways for Mycobacterium tuberculosis; development methodology for consolidation data to determine the average spectrum of sensitivity Mycobacterium tuberculosis and identify genetic families Mycobacterium tuberculosis circulating in the country; determine the hierarchy for bacteriological laboratories with different levels of access to laboratory information-analytical system; creation of the state center microbiological monitoring.

The proposed system microbiological monitoring is a dynamic system of continuous surveillance for the biological characteristics of Mycobacterium tuberculosis, based on the automated registration of laboratory studies and database maintenance. Microbiological monitoring system could serve as a new platform for the analysis of TB situation and make tactical and strategic solutions for TB control.

Keywords. Monitoring drug susceptibility tuberculosis; analysis of laboratory data; microbiological monitoring; laboratory information-analytical system with various levels; the hierarchical organization of data collection and consolidation.

References

1. Belilovskiy Ye.M., Borisov S.Ye., GordinaA.V., Dergachev A.V., Marina N.S., Matveyeva M.V. Kontrol za rasprostraneniyem tuberkuleza v Rossii s ispolzovaniyem kompyuterizirovannoy mnogourovnevoy sistemy monitoringa. [Control over propagation of tuberculosis in Russia with using computerized multi-level monitoring system]. Mezhdunarodnyy forum "Informatizatsiya protsessov okhrany zdorovya naseleniya", Turkey, Kemer, 2001. P. 58-60
2. Borisov S.E., Sokolova G.B. Etiotropnoye lecheniye tuberkuleza pri lekarstvennoy ustoychivosti M.tuberculosis: vzglyady i rekomendatsii mezhdunarodnykh organizatsiy [Etiotropic treatment of drug resistant tuberculosis. M.tuberculosis: opinions and recommendations of international organizations]. Consilium-medicum 2001;3(12):1-25.
3. Vlasov V.V. Effektivnost diagnosticheskikh issledovaniy [Efficiency of diagnostic researches]. Moscow: Meditsina; 1988. 245 p.
4. Metodicheskiye rekomendatsii po lecheniyu rezistentnykh form tuberkuleza [Methodical recommendation on treatment of resistant forms of tuberculosis].WHO. Compilers Kroftan D., Shole P., Grosse Zh., et al. Geneva. 1998. 17 p.
5. Mishin V.Yu. Khimioterapiya tuberkuleza legkikh [Chemotherapy of pulmonary tuberculosis]. Pulmonologiya 2008;(3):5-14.
6. Nechayeva O.B., Son I.M., Eysmont N.V. Perspektivy i vozmozhnosti razvitiya protivotuberkuleznoy sluzhby Rossiyskoy Federatsii [Futures and capabilities of development of TB control service in the Russian Federation]. Sotsialnyye aspekty zdorovya naseleniya [Online Scientific Journal]. 2012;23(1) [cited 2012 Dec 13]. Available from: http://vestnik.mednet.ru/content/view/391/30/lang,ru/
7. Otraslevyye pokazateli protivotuberkuleznoy raboty v 2009 - 2010 g.g. Statisticheskiye materialy sayta www.mednet.ru www.mednet.ru [Sectorial indicators of TB control activity in 2009-2010.]. [Internet] 2010 [cited 2012 Dec 13]. Available from: http://mednet.ru/images/stories/files/CMT/Otraslevye_pokazateli_protivotuberkuleznoi_raboty_2009_2010.pdf
8. Popov S.A., Puzanov V.A., Sabgayda T.P., Antonova N.V., Kazakov A.C. Osnovnyye problemy regionalnykh bakteriologicheskikh laboratoriy protivotuberkuleznykh uchrezhdeniy [The main problems of regional bacteriological laboratories of TB control facilities]. Problemy tuberkuleza i bolezney legkikh 2008;(5): 29-35.
9. Prikaz MZ RF ot 13 fevralya 2004 g. ¹ 50 "O vvedenii v deystviye uchetnoy i otchetnoy dokumentatsii monitoringa tuberkuleza" ["On implementation of accounting and reporting documentation of TB monitoring", the Regulation of the MoH&SD of the RF of February 13. 2004. ¹50]. [Internet]. 2004 [cited 2012 Dec 13]. Available from: http://www.google.ru/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=2&ved=0CDcQFjAB&url=http%3A%2F%2Fgov.cap.ru%2Fhome%2F11%2F43%2Fa22.doc&ei=odbJUOfMCYf44QSQjYHgAw&usg=AFQjCNF6eRJFkk5Hp5m0yoBljVGO6pOcoA&sig2=EkvMDPt73391IFh3zXATOg&bvm=bv.1355272958,d.bGE&cad=rjt
10. Prikaz MZ RF ot 21 marta 2003 g. ¹ 109 «O sovershenstvovanii protivotuberkuleznykh meropriyatiy v Rossiyskoy Federatsii» “On development of TB control measures in the Russian Federation”, the Regulation of the MoH&SD of the RF of March 21. 2003. ¹109]. [Internet]. 2003 [cited 2012 Dec 13]. Available from: http://www.45.rospotrebnadzor.ru/273/-/asset_publisher/4IjW/content/%D0%BF%D1%80%D0%B8%D0%BA%D0%B0%D0%B7-%D0%BC%D0%B7-%D1%80%D1%84-%E2%84%96-109-%D0%BE%D1%82-21-03-2003-%D0%B3-%D0%BE-%D1%81%D0%BE%D0%B2%D0%B5%D1%80%D1%88%D0%B5%D0%BD%D1%81%D1%82%D0%B2%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D0%B8-%D0%BF%D1%80%D0%BE%D1%82%D0%B8%D0%B2%D0%BE%D1%82%D1%83%D0%B1%D0%B5%D1%80%D0%BA%D1%83%D0%BB%D0%B5%D0%B7%D0%BD%D1%8B%D1%85-%D0%BC%D0%B5%D1%80%D0%BE%D0%BF%D1%80%D0%B8%D1%8F%D1%82%D0%B8%D0%B8-%D0%B2-%D1%80%D1%84
11. Tuberkulez v Rossiyskoy Federatsii, 2010 g. Analiticheskiy obzor po tuberkulezu v Rossiyskoy Federatsii za 2010 god. [Tuberculosis in the Russian Federation, 2010. Analytical review on tuberculosis in the Russian Federation for 2010]. Moscow. 2011. 280 p.
12. Cohen T. Identification of high-risk subgroups: application of novel methods to existing surveillance data. In: Abstract book 42nd World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union). The International Journal of Tuberculosis and Lung Disease 2011;15(11) supplement 3. S11
13. Global tuberculosis control: WHO report 2011. World Health Organization. Geneva: World Health Organization. 2011. viii. 246 p. [Internet] 2011 [cited 2012 Dec 13]. Available from: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf
14. Jenkins HE, M Zignol, T Cohen. Quantifying the burden and trends of isoniazid-resistant tuberculosis, 1994–2009. In: Abstract book 42nd World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union). The International Journal of Tuberculosis and Lung Disease 2011;15(11) supplement 3. S102
15. Leung ECC, Leung CC, Kam KM, Yew WW, Chang KC, Leung WM, and Tam CM. Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. Eur Respir J. 2012.
16. Masoud Dara, Hans Kluge. Roadmap to prevent and combat drug-resistant tuberculosis : the consolidated action plan to prevent and combat multidrug- and extensively drug-resistant tuberculosis in the WHO European Region 2011-2015; World Health Organization. Regional Office for Europe. Copenhagen: WHO Regional Office for Europe. 2011. vi. 103 p. [Internet]. 2011 [cited 2012 Dec 13]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0014/152015/e95786.pdf
17. Shah NS, Wright A, Bai G-H, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 2007;13:380–387.
18. Walter ND, Strong M, Belknap R, Ordway DJ, Daley CL, Chan ED. Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis. Respirology 2012;17(5):772–791. Online publish 25 JUN 2012 [cited 2012 Dec 13]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1843.2012.02176.x/full
19. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland: World Health Organization; 2006. WHO/HTM/TB/2006.361.
20. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. 2010. Geneva. 71 p. [Internet]. 2010 [cited 2012 Dec 13]. Available from: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
21. Zhang J, Mi L, Wang Y, Liu P, Liang H, Huang Y, Lv B, Yuan L. Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province. China. BMC Res Notes 2012;(5):309. Published online 2012 June 19 [cited 2012 Dec 13]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441358/

Write Comment

Please keep the topic of messages relevant to the subject of the article. Personal verbal attacks will be deleted. Please don't use comments to plug your web site. Such material will be removed. Just ensure to *Refresh* your browser for a new security code to be displayed prior to clicking on the 'Send' button. Keep in mind that the above process only applies if you simply entered the wrong security code.
Name:
E-mail
Comment:
Code:*